ATE1 antibody (N-Term)
Quick Overview for ATE1 antibody (N-Term) (ABIN630829)
Target
See all ATE1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- ATE1 antibody was raised against the N terminal of ATE1
-
Purification
- Affinity purified
-
Immunogen
- ATE1 antibody was raised using the N terminal of ATE1 corresponding to a region with amino acids CCPQYTIRCRPLQFQPSKSHKKVLKKMLKFLAKGEVPKGSCEDEPMDSTM
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
ATE1 Blocking Peptide, (ABIN937040), is also available for use as a blocking control in assays to test for specificity of this ATE1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ATE1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ATE1 (Arginyltransferase 1 (ATE1))
-
Alternative Name
- ATE1
-
Background
- ATE1 is an arginyltransferase, an enzyme that is involved in posttranslational conjugation of arginine to N-terminal aspartate or glutamate residues. Conjugation of arginine to the N-terminal aspartate or glutamate targets proteins for ubiquitin-dependent degradation. Alternative splicing results in two transcript variants encoding distinct isoforms.
-
Molecular Weight
- 59 kDa (MW of target protein)
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-